-  This bill is not active in this session.
 

A02904 Summary:

BILL NOA02904
 
SAME ASSAME AS S04808
 
SPONSORQuart
 
COSPNSRWeprin, Carroll, Richardson
 
MLTSPNSRTague
 
Amd §§3216, 3221 & 4303, rpld §3216 sub§ (i) ¶31-a, §3221 sub§ (l) ¶¶7-a & 7-b, §4303 sub§§ (l-1) & (l-2), Ins L
 
Prohibits certain insurance policies from requiring prior authorization for buprenorphine products, methadone and long acting injectable naltrexone for detoxification or maintenance treatment of substance use disorders.
Go to top    

A02904 Actions:

BILL NOA02904
 
01/28/2019referred to insurance
03/12/2019reported referred to codes
03/18/2019reported
03/21/2019advanced to third reading cal.152
04/10/2019passed assembly
04/10/2019delivered to senate
04/10/2019REFERRED TO INSURANCE
06/03/2019SUBSTITUTED FOR S4808
06/03/20193RD READING CAL.1142
06/03/2019PASSED SENATE
06/03/2019RETURNED TO ASSEMBLY
12/19/2019delivered to governor
12/31/2019signed chap.748
Go to top

A02904 Committee Votes:

INSURANCE Chair:Cahill DATE:03/12/2019AYE/NAY:23/0 Action: Favorable refer to committee Codes
CahillAyeGarbarinoAye
CookAyeHawleyAye
PretlowAyeBlankenbushAye
RiveraAyeFinchExcused
CymbrowitzAyeRaiaAye
LavineAyePalmesanoAye
SteckAyeByrneAye
DilanAye
HunterAye
SimotasAye
WalkerAye
NiouAye
RosenthalAye
SternAye
McDonaldAye
RomeoAye
JacobsonAye

CODES Chair:Lentol DATE:03/18/2019AYE/NAY:21/0 Action: Favorable
LentolAyeRaAye
SchimmingerAyeGiglioAye
PretlowAyeMontesanoAye
CookAyeMorinelloAye
CymbrowitzAyePalumboAye
O'DonnellAbsentGarbarinoAye
LavineAye
PerryAye
ZebrowskiAye
AbinantiAye
WeprinAye
MosleyAye
HevesiAye
FahyAye
SeawrightAye
RosenthalAye

Go to top

A02904 Floor Votes:

DATE:04/10/2019Assembly Vote  YEA/NAY: 139/2
AbbateYCrespoYGanttERLiPetriYPerryYSimonY
AbinantiYCrouchYGarbarinoYLupardoYPheffer AmatoYSimotasY
ArroyoYCruzYGiglioYMagnarelliYPichardoERSmithY
AshbyYCusickYGlickYMalliotakisYPretlowYSmullenY
AubryYCymbrowitzYGoodellNOManktelowYQuartYSolagesY
BarclayYDavilaYGottfriedYMcDonaldYRaYStecY
BarnwellYDe La RosaYGriffinYMcDonoughYRaiaYSteckY
BarrettYDenDekkerYGuntherYMcMahonYRamosERSternY
BarronYDeStefanoYHawleyYMikulinYRaynorYStirpeY
BenedettoYDickensYHevesiYMiller B YReillyYTagueY
BichotteERDilanYHunterYMiller MGYReyesYTaylorY
BlakeYDinowitzYHyndmanYMiller MLERRichardsonYThieleY
BlankenbushYDiPietroYJacobsonYMontesanoERRiveraYTitusY
BrabenecYD'UrsoYJaffeeYMorinelloYRodriguezERVanelY
BraunsteinYEichensteinYJean-PierreYMosleyYRomeoYWalczykY
BronsonYEnglebrightYJohnsYNiouYRosenthal D YWalkerY
BuchwaldYEpsteinYJonesYNolanERRosenthal L YWallaceY
BurkeYFahyYJoynerYNorrisYRozicYWalshY
ButtenschonYFallYKimYO'DonnellYRyanERWeinsteinY
ByrneYFernandezYKolbYOrtizYSalkaYWeprinY
ByrnesYFinchYLalorYOtisYSantabarbaraYWilliamsY
CahillYFitzpatrickYLavineYPalmesanoYSayeghYWoernerY
CarrollYFriendNOLawrenceYPalumboYSchimmingerYWrightY
ColtonYFrontusYLentolYPaulinYSchmittYZebrowskiY
CookYGalefYLiftonYPeoples-StokesYSeawrightYMr. SpeakerY

Go to top

A02904 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          2904
 
                               2019-2020 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 28, 2019
                                       ___________
 
        Introduced  by M. of A. QUART -- read once and referred to the Committee
          on Insurance
 
        AN ACT to amend the insurance law, in relation  to  prohibiting  certain
          insurance  policies  from  requiring  prior  authorization for certain
          medications used in the treatment of substance use disorders;  and  to
          repeal certain provisions of such law relating thereto
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Paragraph 31-a of subsection (i) of  section  3216  of  the
     2  insurance  law  is REPEALED and a new paragraph 31-a is added to read as
     3  follows:
     4    (31-a) (A) No policy that provides medical, major medical  or  similar
     5  comprehensive-type coverage and provides coverage for prescription drugs
     6  for  medication  for  the  treatment  of  a substance use disorder shall
     7  require prior authorization for an initial or renewal  prescription  for
     8  all buprenorphine products, methadone or long acting injectable naltrex-
     9  one  for  detoxification  or  maintenance  treatment  of a substance use
    10  disorder except where otherwise prohibited by law.
    11    (B) Coverage provided under this paragraph may be  subject  to  copay-
    12  ments,  coinsurance,  and  annual  deductibles  that are consistent with
    13  those imposed on other benefits within the policy.
    14    § 2. Paragraphs 7-a and 7-b of subsection (l) of section 3221  of  the
    15  insurance  law  are REPEALED and a new paragraph 7-a is added to read as
    16  follows:
    17    (7-a) (A) Every policy that provides medical, major medical or similar
    18  comprehensive-type large group coverage shall provide immediate coverage
    19  for all buprenorphine products,  methadone  or  long  acting  injectable
    20  naltrexone without prior authorization for the detoxification or mainte-
    21  nance treatment of a substance use disorder.

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD01428-01-9

        A. 2904                             2
 
     1    (B)  Coverage  provided  under this paragraph may be subject to copay-
     2  ments, coinsurance, and annual  deductibles  that  are  consistent  with
     3  those imposed on other benefits within the policy.
     4    §  3. Subsections (l-1) and (l-2) of section 4303 of the insurance law
     5  are REPEALED and a new subsection (l-1) is added to read as follows:
     6    (l-1) (A) Every contract that  provides  medical,  major  medical,  or
     7  similar  comprehensive-type large group coverage shall provide immediate
     8  coverage for  all  buprenorphine  products,  methadone  or  long  acting
     9  injectable naltrexone without prior authorization for the detoxification
    10  or maintenance treatment of a substance use disorder.
    11    (B)  Coverage  provided  under this paragraph may be subject to copay-
    12  ments, coinsurance, and annual  deductibles  that  are  consistent  with
    13  those imposed on other benefits within the policy.
    14    §  4.  This  act  shall take effect on the sixtieth day after it shall
    15  have become a law.
Go to top